The Radiopharmaceuticals Division of Radiopharma is a world-class nuclear medicine company, headquartered in Montreal, Canada, with a solid foundation in specialty pharma. They develop, manufacture and commercialize radiopharmaceuticals worldwide used for the diagnosis and treatment of various diseases. The company has over 170 highly skilled employees dedicated to providing high quality and reliable products to health care providers for more than 60 years. Our broad portfolio of products includes diagnostic and therapeutic agents, as well as state-of-the-art devices, for cardiology, oncology, pulmonology, and endocrinology. Their corporate values focus on cultivating world-class talent committed to quality and innovation, with a promise of providing the highest quality radiopharmaceuticals and advanced technologies to healthcare professionals, so they can provide the highest quality care to their patients.